Prognostic factors related to cervical cancer survival in Mexican women

Abstract
Objective: To identify prognostic survival factors among Mexican women with cervical cancer.Methods: A total of 378 women with cervical cancer admitted from 1984 to 1996 to our referral hospital were evaluated, using survival analysis (Kaplan–Meier and Cox proportional hazards method). We designed a symptom index which included asymptomatic conditions, severity of symptoms and comorbidity.Results: Overall 5‐year survival was 66.6%. The shortest survival time was for FIGO stage IV (21.5%,PP=0.15). The main prognostic factors were primary symptoms (RR, 2.6; 95% CI, 1.02–6.66); systemic symptoms (RR, 3.3; 95% CI, 1.23–9.01); FIGO stage IV (RR, 5.5; 95% CI, 2.36–12.96); and oncogenic symptoms (prognostic comorbidity present) (RR, 2.3; 95% CI, 1.08–4.89).Conclusions: Our findings show that clinical stage and several types of symptoms influence CC survival. This present strategy to assess morphological and clinical characteristics may be a more accurate indicator of survival rate and potentially an efficient indicator of new therapeutic alternatives.